Julie Kim

Julie brings diverse experience in both healthcare investments and drug development. Prior to Walking Fish Therapeutics, she served as Vice president at Quan Capital, responsible for execution and management of biotech investments and served as board observer to several start-up companies, including Walking Fish Therapeutics. Prior to joining Quan Capital, she spent 8 years at Roche and Genentech, in increasing senior roles in pharma partnering, external alliances and oncology clinical operations, and serving in global leadership roles in multiple therapeutic areas including infectious diseases, virology and oncology.

Julie received a Pharm.D. from University of California San Diego, a M.S. in Chemistry from University of San Francisco, and B.A. in Chemistry and Music from Emory University.